Home > > > > Report Detail

Global Pneumococcal Vaccine Market Growth 2020-2025

Publisher Name :
Date: 05-Oct-2020
No. of pages: 137

According to this study, over the next five years the Pneumococcal Vaccine market will register a 1.1%% CAGR in terms of revenue, the global market size will reach $ 7204.8 million by 2025, from $ 6885.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pneumococcal Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Pneumococcal Vaccine, covering the supply chain analysis, impact assessment to the Pneumococcal Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Pneumococcal Vaccine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- PPSV 23

- PCV 7/13

- PCV 10

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Child

- Adult

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Pfizer

- GSK

- Sanofipasteur

- CDIBP

- MSD

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Pneumococcal Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Pneumococcal Vaccine market by identifying its various subsegments.

- Focuses on the key global Pneumococcal Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Pneumococcal Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Pneumococcal Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Pneumococcal Vaccine Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pneumococcal Vaccine Consumption 2015-2025
2.1.2 Pneumococcal Vaccine Consumption CAGR by Region
2.2 Pneumococcal Vaccine Segment by Type
2.2.1 PPSV 23
2.2.2 PCV 7/13
2.2.3 PCV 10
2.3 Pneumococcal Vaccine Consumption by Type
2.3.1 Global Pneumococcal Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Pneumococcal Vaccine Sale Price by Type (2015-2020)
2.4 Pneumococcal Vaccine Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Vaccine Consumption by Application
2.5.1 Global Pneumococcal Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Pneumococcal Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Pneumococcal Vaccine Sale Price by Type (2015-2020)

3 Global Pneumococcal Vaccine by Company
3.1 Global Pneumococcal Vaccine Sales Market Share by Company
3.1.1 Global Pneumococcal Vaccine Sales by Company (2018-2020)
3.1.2 Global Pneumococcal Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Pneumococcal Vaccine Revenue Market Share by Company
3.2.1 Global Pneumococcal Vaccine Revenue by Company (2018-2020)
3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Pneumococcal Vaccine Sale Price by Company
3.4 Global Pneumococcal Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Pneumococcal Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Pneumococcal Vaccine by Regions
4.1 Pneumococcal Vaccine by Regions
4.2 Americas Pneumococcal Vaccine Consumption Growth
4.3 APAC Pneumococcal Vaccine Consumption Growth
4.4 Europe Pneumococcal Vaccine Consumption Growth
4.5 Middle East & Africa Pneumococcal Vaccine Consumption Growth

5 Americas
5.1 Americas Pneumococcal Vaccine Consumption by Countries
5.1.1 Americas Pneumococcal Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Pneumococcal Vaccine Value by Countries (2015-2020)
5.2 Americas Pneumococcal Vaccine Consumption by Type
5.3 Americas Pneumococcal Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Pneumococcal Vaccine Consumption by Regions
6.1.1 APAC Pneumococcal Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Pneumococcal Vaccine Value by Regions (2015-2020)
6.2 APAC Pneumococcal Vaccine Consumption by Type
6.3 APAC Pneumococcal Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Pneumococcal Vaccine by Countries
7.1.1 Europe Pneumococcal Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Pneumococcal Vaccine Value by Countries (2015-2020)
7.2 Europe Pneumococcal Vaccine Consumption by Type
7.3 Europe Pneumococcal Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Pneumococcal Vaccine by Countries
8.1.1 Middle East & Africa Pneumococcal Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Pneumococcal Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Pneumococcal Vaccine Consumption by Type
8.3 Middle East & Africa Pneumococcal Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pneumococcal Vaccine Distributors
10.3 Pneumococcal Vaccine Customer

11 Global Pneumococcal Vaccine Market Forecast
11.1 Global Pneumococcal Vaccine Consumption Forecast (2021-2025)
11.2 Global Pneumococcal Vaccine Forecast by Regions
11.2.1 Global Pneumococcal Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Pneumococcal Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pneumococcal Vaccine Forecast by Type
11.8 Global Pneumococcal Vaccine Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Pneumococcal Vaccine Product Offered
12.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Pneumococcal Vaccine Product Offered
12.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 Sanofipasteur
12.3.1 Company Information
12.3.2 Pneumococcal Vaccine Product Offered
12.3.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sanofipasteur Latest Developments
12.4 CDIBP
12.4.1 Company Information
12.4.2 Pneumococcal Vaccine Product Offered
12.4.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 CDIBP Latest Developments
12.5 MSD
12.5.1 Company Information
12.5.2 Pneumococcal Vaccine Product Offered
12.5.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 MSD Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Pneumococcal Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of PPSV 23
Table 5. Major Players of PCV 7/13
Table 6. Major Players of PCV 10
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Pneumococcal Vaccine Consumption Market Share by Type (2015-2020)
Table 9. Global Pneumococcal Vaccine Revenue by Type (2015-2020) ($ million)
Table 10. Global Pneumococcal Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Pneumococcal Vaccine Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Pneumococcal Vaccine Consumption Market Share by Application (2015-2020)
Table 14. Global Pneumococcal Vaccine Value by Application (2015-2020)
Table 15. Global Pneumococcal Vaccine Value Market Share by Application (2015-2020)
Table 16. Global Pneumococcal Vaccine Sale Price by Application (2015-2020)
Table 17. Global Pneumococcal Vaccine Sales by Company (2017-2019) (K Doses)
Table 18. Global Pneumococcal Vaccine Sales Market Share by Company (2017-2019)
Table 19. Global Pneumococcal Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Pneumococcal Vaccine Revenue Market Share by Company (2017-2019)
Table 21. Global Pneumococcal Vaccine Sale Price by Company (2017-2019)
Table 22. Global Pneumococcal Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Pneumococcal Vaccine Products Offered
Table 24. Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Pneumococcal Vaccine Consumption by Regions 2015-2020 (K Doses)
Table 26. Global Pneumococcal Vaccine Consumption Market Share by Regions 2015-2020
Table 27. Global Pneumococcal Vaccine Value by Regions 2015-2020 ($ Millions)
Table 28. Global Pneumococcal Vaccine Value Market Share by Regions 2015-2020
Table 29. Americas Pneumococcal Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 30. Americas Pneumococcal Vaccine Consumption Market Share by Countries (2015-2020)
Table 31. Americas Pneumococcal Vaccine Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Pneumococcal Vaccine Value Market Share by Countries (2015-2020)
Table 33. Americas Pneumococcal Vaccine Consumption by Type (2015-2020) (K Doses)
Table 34. Americas Pneumococcal Vaccine Consumption Market Share by Type (2015-2020)
Table 35. Americas Pneumococcal Vaccine Consumption by Application (2015-2020) (K Doses)
Table 36. Americas Pneumococcal Vaccine Consumption Market Share by Application (2015-2020)
Table 37. APAC Pneumococcal Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 38. APAC Pneumococcal Vaccine Consumption Market Share by Countries (2015-2020)
Table 39. APAC Pneumococcal Vaccine Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Pneumococcal Vaccine Value Market Share by Regions (2015-2020)
Table 41. APAC Pneumococcal Vaccine Consumption by Type (2015-2020) (K Doses)
Table 42. APAC Pneumococcal Vaccine Consumption Market Share by Type (2015-2020)
Table 43. APAC Pneumococcal Vaccine Consumption by Application (2015-2020) (K Doses)
Table 44. APAC Pneumococcal Vaccine Consumption Market Share by Application (2015-2020)
Table 45. Europe Pneumococcal Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 46. Europe Pneumococcal Vaccine Consumption Market Share by Countries (2015-2020)
Table 47. Europe Pneumococcal Vaccine Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Pneumococcal Vaccine Value Market Share by Countries (2015-2020)
Table 49. Europe Pneumococcal Vaccine Consumption by Type (2015-2020) (K Doses)
Table 50. Europe Pneumococcal Vaccine Consumption Market Share by Type (2015-2020)
Table 51. Europe Pneumococcal Vaccine Consumption by Application (2015-2020) (K Doses)
Table 52. Europe Pneumococcal Vaccine Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Pneumococcal Vaccine Consumption by Countries (2015-2020) (K Doses)
Table 54. Middle East & Africa Pneumococcal Vaccine Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Pneumococcal Vaccine Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Pneumococcal Vaccine Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Pneumococcal Vaccine Consumption by Type (2015-2020) (K Doses)
Table 58. Middle East & Africa Pneumococcal Vaccine Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Pneumococcal Vaccine Consumption by Application (2015-2020) (K Doses)
Table 60. Middle East & Africa Pneumococcal Vaccine Consumption Market Share by Application (2015-2020)
Table 61. Pneumococcal Vaccine Distributors List
Table 62. Pneumococcal Vaccine Customer List
Table 63. Global Pneumococcal Vaccine Consumption Forecast by Countries (2021-2025) (K Doses)
Table 64. Global Pneumococcal Vaccine Consumption Market Forecast by Regions
Table 65. Global Pneumococcal Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Pneumococcal Vaccine Value Market Share Forecast by Regions
Table 67. Global Pneumococcal Vaccine Consumption Forecast by Type (2021-2025) (K Doses)
Table 68. Global Pneumococcal Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Pneumococcal Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Pneumococcal Vaccine Value Market Share Forecast by Type (2021-2025)
Table 71. Global Pneumococcal Vaccine Consumption Forecast by Application (2021-2025) (K Doses)
Table 72. Global Pneumococcal Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Pneumococcal Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Pneumococcal Vaccine Value Market Share Forecast by Application (2021-2025)
Table 75. Pfizer Product Offered
Table 76. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. Pfizer Basic Information, Company Total Revenue (in $ million), Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. GSK Product Offered
Table 81. GSK Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 82. GSK Main Business
Table 83. GSK Latest Developments
Table 84. GSK Basic Information, Company Total Revenue (in $ million), Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofipasteur Product Offered
Table 86. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 87. Sanofipasteur Main Business
Table 88. Sanofipasteur Latest Developments
Table 89. Sanofipasteur Basic Information, Company Total Revenue (in $ million), Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. CDIBP Product Offered
Table 91. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 92. CDIBP Main Business
Table 93. CDIBP Latest Developments
Table 94. CDIBP Basic Information, Company Total Revenue (in $ million), Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. MSD Product Offered
Table 96. MSD Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 97. MSD Main Business
Table 98. MSD Latest Developments
Table 99. MSD Basic Information, Company Total Revenue (in $ million), Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Pneumococcal Vaccine
Figure 2. Pneumococcal Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Pneumococcal Vaccine Consumption Growth Rate 2015-2025 (K Doses)
Figure 5. Global Pneumococcal Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of PPSV 23
Figure 7. Product Picture of PCV 7/13
Figure 8. Product Picture of PCV 10
Figure 9. Global Pneumococcal Vaccine Consumption Market Share by Type (2015-2020)
Figure 10. Global Pneumococcal Vaccine Value Market Share by Type (2015-2020)
Figure 11. Pneumococcal Vaccine Consumed in Child
Figure 12. Global Pneumococcal Vaccine Market: Child (2015-2020) (K Doses)
Figure 13. Global Pneumococcal Vaccine Market: Child (2015-2020) ($ Millions)
Figure 14. Pneumococcal Vaccine Consumed in Adult
Figure 15. Global Pneumococcal Vaccine Market: Adult (2015-2020) (K Doses)
Figure 16. Global Pneumococcal Vaccine Market: Adult (2015-2020) ($ Millions)
Figure 17. Global Pneumococcal Vaccine Consumption Market Share by Application (2015-2020)
Figure 18. Global Pneumococcal Vaccine Value Market Share by Application (2015-2020)
Figure 19. Global Pneumococcal Vaccine Sales Market Share by Company in 2017
Figure 20. Global Pneumococcal Vaccine Sales Market Share by Company in 2019
Figure 21. Global Pneumococcal Vaccine Revenue Market Share by Company in 2017
Figure 22. Global Pneumococcal Vaccine Revenue Market Share by Company in 2019
Figure 23. Global Pneumococcal Vaccine Sale Price by Company in 2019
Figure 24. Global Pneumococcal Vaccine Consumption Market Share by Regions 2015-2020
Figure 25. Global Pneumococcal Vaccine Value Market Share by Regions 2015-2020
Figure 26. Americas Pneumococcal Vaccine Consumption 2015-2020 (K Doses)
Figure 27. Americas Pneumococcal Vaccine Value 2015-2020 ($ Millions)
Figure 28. APAC Pneumococcal Vaccine Consumption 2015-2020 (K Doses)
Figure 29. APAC Pneumococcal Vaccine Value 2015-2020 ($ Millions)
Figure 30. Europe Pneumococcal Vaccine Consumption 2015-2020 (K Doses)
Figure 31. Europe Pneumococcal Vaccine Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Pneumococcal Vaccine Consumption 2015-2020 (K Doses)
Figure 33. Middle East & Africa Pneumococcal Vaccine Value 2015-2020 ($ Millions)
Figure 34. Americas Pneumococcal Vaccine Consumption Market Share by Countries in 2019
Figure 35. Americas Pneumococcal Vaccine Value Market Share by Countries in 2019
Figure 36. Americas Pneumococcal Vaccine Consumption Market Share by Type in 2019
Figure 37. Americas Pneumococcal Vaccine Consumption Market Share by Application in 2019
Figure 38. United States Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 39. United States Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 41. Canada Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 43. Mexico Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Pneumococcal Vaccine Consumption Market Share by Countries in 2019
Figure 45. APAC Pneumococcal Vaccine Value Market Share by Regions in 2019
Figure 46. APAC Pneumococcal Vaccine Consumption Market Share by Type in 2019
Figure 47. APAC Pneumococcal Vaccine Consumption Market Share by Application in 2019
Figure 48. China Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 49. China Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 51. Japan Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 53. Korea Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 55. Southeast Asia Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 56. India Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 57. India Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 59. Australia Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Pneumococcal Vaccine Consumption Market Share by Countries in 2019
Figure 61. Europe Pneumococcal Vaccine Value Market Share by Countries in 2019
Figure 62. Europe Pneumococcal Vaccine Consumption Market Share by Type in 2019
Figure 63. Europe Pneumococcal Vaccine Consumption Market Share by Application in 2019
Figure 64. Germany Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 65. Germany Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 66. France Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 67. France Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 68. UK Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 69. UK Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 71. Italy Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 73. Russia Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Pneumococcal Vaccine Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Pneumococcal Vaccine Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Pneumococcal Vaccine Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Pneumococcal Vaccine Consumption Market Share by Application in 2019
Figure 78. Egypt Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 79. Egypt Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 81. South Africa Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 83. Israel Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 85. Turkey Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Pneumococcal Vaccine Consumption Growth 2015-2020 (K Doses)
Figure 87. GCC Countries Pneumococcal Vaccine Value Growth 2015-2020 ($ Millions)
Figure 88. Global Pneumococcal Vaccine Consumption Growth Rate Forecast (2021-2025) (K Doses)
Figure 89. Global Pneumococcal Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 91. Americas Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 92. APAC Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 93. APAC Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 94. Europe Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 95. Europe Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 97. Middle East & Africa Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 98. United States Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 99. United States Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 100. Canada Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 101. Canada Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 102. Mexico Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 103. Mexico Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 104. Brazil Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 105. Brazil Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 106. China Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 107. China Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 108. Japan Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 109. Japan Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 110. Korea Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 111. Korea Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 113. Southeast Asia Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 114. India Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 115. India Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 116. Australia Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 117. Australia Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 118. Germany Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 119. Germany Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 120. France Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 121. France Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 122. UK Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 123. UK Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 124. Italy Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 125. Italy Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 126. Russia Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 127. Russia Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 128. Spain Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 129. Spain Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 130. Egypt Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 131. Egypt Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 132. South Africa Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 133. South Africa Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 134. Israel Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 135. Israel Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 136. Turkey Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 137. Turkey Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Pneumococcal Vaccine Consumption 2021-2025 (K Doses)
Figure 139. GCC Countries Pneumococcal Vaccine Value 2021-2025 ($ Millions)
Figure 140. Pfizer Pneumococcal Vaccine Market Share (2018-2020)
Figure 141. GSK Pneumococcal Vaccine Market Share (2018-2020)
Figure 142. Sanofipasteur Pneumococcal Vaccine Market Share (2018-2020)
Figure 143. CDIBP Pneumococcal Vaccine Market Share (2018-2020)
Figure 144. MSD Pneumococcal Vaccine Market Share (2018-2020)
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs